Secondary hyperparathyroidism (SHPT) is a major problem for patients with chronic kidney
disease and can cause many complications, including osteodystrophy, fractures, and …

The situation of secondary hyperparathyroidism (SHPT) in chronic kidney disease patients
not on dialysis (ND-CKD) is probably best characterised by the Kidney Disease: Improving …

Objective: Hyperparathyroidism (HPT) is nearly universal in patients with end-stage kidney
disease. Kidney transplantation (KT) reverses HPT in many patients, but most studies have …

Systemic acid–base status is primarily determined by the interplay of net acid production
(NEAP) arising from metabolism of ingested food stuffs, buffering of NEAP in tissues …

Introduction Little is known about the consequences of deranged chronic kidney disease–
mineral and bone disorder (CKD-MBD) parameters on kidney allograft function in children …

Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the
kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover …

Chronic kidney disease (CKD) is a prevalent pathological condition worldwide. Parathyroid
hormone (PTH) is an important index related to bone metabolism in CKD patients and has …

Introduction: Chronic kidney disease (CKD) drives onerous human and healthcare costs,
underscoring an urgent need to avert disease progression. Secondary hyperparathyroidism …

Background Chronic kidney disease–mineral and bone disorder (CKD-MBD) is a common
complication of CKD; it is associated with higher mortality in dialysis patients, while its …

This real-world analysis evaluated the clinical and economic burden of non-dialysis-
dependent CKD patients with and without secondary hyperparathyroidism (sHPT) in Italy. An …